.
9969 financial statements
* Numbers in millions
Year |
2020 | TTM |
|---|---|---|
Capitalization * |
13 082 | 10 063 |
EV * |
10 286 | 10 286 |
Stock price ¤ |
13.52 | 10.4 |
Number of shares * |
968 | 968 |
EPS |
-0,48 | -0,48 |
Revenue * |
1 | 1 |
Net income * |
-464 | -464 |
Operating profit * |
-495 | -495 |
Total liabilities * |
1 377 | 1 377 |
Net debt * |
-2 796 | -2 796 |
Total assets * |
4 538 | 4 538 |
Equity * |
3 104 | 3 104 |
Cash and investments * |
3 970 | 3 970 |
Over the past 10 years, the maximum capitalization of InnoCare Pharma Limited is 13 082, the minimum is 13 082. Maximum net income 0, Minimum net income -464. The maximum price of 9969 shares is 13.52, the minimum price is 13.52.
.
9969 valuation
Year |
2020 | TTM |
|---|---|---|
P/E |
-28,21 | -21,70 |
P/B |
4,21 | 3,24 |
P/S |
9 590,64 | 7 377,42 |
E/P |
-4% | -5% |
P/FCF |
-30,87 | -23,75 |
.
9969 profitability
Year |
2020 | TTM |
|---|---|---|
ROE |
-15% | |
ROA |
-10% | |
ROIC |
-11% |